GENETESIS NEWSROOM

What's New With Genetesis

Stay up-to-date with the latest Genetesis headlines, including product updates, research announcements, and more.

Press Releases
AWARDS
MEDIA COVERAGE
BRAND ASSETS
December 20, 2024

City of Mason and Genetesis Announce Expanded Partnership as Mason Becomes First Commercial Adopter of CardioFlux Membership through Living Lab Initiative

Read More
December 11, 2024

Genetesis Launches CardioFlux Membership Program to Revolutionize Preventive Cardiac Care and Eliminate Heart Disease

Read More
September 19, 2024

Health Canada Approves CardioFlux MCG for the Diagnosis of Myocardial Ischemia

Read More
recognized for our work

Our Awards & Recognition

2022 Forbes 30 Under 30 Recepient in Healthcare
2019 Cincy Inno's Coolest Companies
VentureOhio's 2017 Seed Stage Company of the Year & 2018 Early Stage Company
Nvidia Inception Award for Best AI Social Impact Startup
ARPA-H Investor Catalyst Hub Spoke Member

Media Coverage

April 14, 2023

FDA grants breakthrough device status for Genetesis’ CardioFlux MCG

Read More
November 29, 2022

Genetesis Founder Named Forbes 30 Under 30

Read More
October 6, 2020

Ms. Medicine and Genetesis Initiate WACE-MCG Clinical Registry

Read More
January 6, 2021

CardioFlux Magnetocardiograph Case Studies

Read More
January 31, 2021

Genetesis Applauds CMS’s MCIT Rule to Prove National Medicare Coverage For FDA Breakthrough Devices

Read More
April 1, 2020

COVID-19 Further Overwhelms Chest Pain Triage Inefficiencies

Read More

Media Kit

Couldn't find what you need? Reach out through our contact form.

Media Kit

Our current guidelines and brand photography including founder headshots and device photos.

Logo Download

Download the primary Genetesis logo or any of its varied colors and lockups.